Wall Street prepared for major earnings and economic data ahead of a blockbuster week that could shake markets.

Intel’s top line is projected to decline again this year - suggesting revenue stagnation could become the norm.

The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and ...

Stock futures are pointing to a higher open on Tuesday, putting major indexes on track to hit new record highs, as investors ...

Shares in Danish drugmaker Novo Nordisk were down nearly 20% in pre-market trading Tuesday morning after the company cuts its ...

US stocks were mixed Monday and the S&P 500 eked out a record high for the sixth day in a row as investors digested the ...

Key Takeaways Shares in Meta Platforms rose to start the week ahead of the tech giant’s highly anticipated quarterly earnings ...

In the last five years, Microsoft’s stock has displayed a slight inclination towards negative one-day returns following ...

Earnings are in the midst of a "rolling recovery" that'll boost the S&P 500. AI, fiscal policy, and rate cuts will help the ...

Investors kick off a hectic week with stocks moving mostly lower after a U.S.-European Union trade deal, with a Fed meeting, jobs data and a deluge of corporate earnings on deck.

Tesla faces declining sales, contracting margins, and brand damage, with increased competition eroding its market share in ...

Recent 20% drop in Embraer shares reflects fear, not fundamentals. Read why 50% tariff hike on Brazilian products is an ...